Bioengine Capital Inc. 3
3 · WINDTREE THERAPEUTICS INC /DE/ · Filed Mar 21, 2019
Insider Transaction Report
Form 3
Bioengine Capital Inc.
10% Owner
Holdings
SERIES F WARRANTS
Exercise: $3.68From: 2018-12-24Exp: 2020-06-24→ COMMON STOCK (384,824 underlying)- 3,551,750
COMMON STOCK
SERIES G WARRANTS
Exercise: $4.05From: 2018-12-24Exp: 2023-12-24→ COMMON STOCK (747,012 underlying)
Footnotes (3)
- [F1]The shares are directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc., which owns 58.6% of Bioengine Capital Inc.
- [F2]The exercisable shares of Series F Warrants will be directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc.
- [F3]The exercisable shares of Series G Warrants will be directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc.